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Abstract 
In addition to a, 6 and &-protein kinase C, murine erythroleukemia cells contain [-PKC and also a c-PKC isoform, named cc,, which shows 
cross-reactivity with an anti-a-PKC antipeptide antibody. In a C44 MEL, ccl1 clone, characterized by a high rate of differentiation, both c-PKC forms 
are expressed at a level higher than that of the N23 MEL cell clone which differentiates at a low rate and contains higher levels of E-PKC and 
particularly of the &PKC isozyme. In the course of MEL cell differentiation, 6-PKC in N23 cells and a,-PKC in C44 cells are rapidly down-regulated 
and the overall process is almost completed before cell commitment. Of the other three PKC isozymes present in both clones, only a-PKC is 
down-regulated to a significant extent. It is proposed that modulation of the signal delivered by each PKC isozyme is one of the biochemical 
mechanisms involved in MEL cell differentiation. 
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1. Introduction 
Protein kinase C (EC 2.7.1.37) belongs to a family of 
enzymes that are represented in a variety different 
isoforms in almost all mammalian cells [ 11. In MEL cells 
two isoforms, a and /3, of the c-PKC subfamily [2], have 
been separated and identified [3]. The presence of the 
a-PKC type was later confirmed whereas the second 
PKC activity was proved not to belong to the /3-PKC 
isotype [4] thus leaving unsolved the nature of this un- 
known PKC isoform. Two isozymic forms, E-PKC [4] 
and S-PKC [5], belonging to the n-PKC subfamily [2], 
were also found to be expressed in these cells. 
In terms of biological function the following observa- 
tions suggested that these different PKCs could play an 
important role in cell differentiation. (i) In MEL cell 
clones the’ sensitivity to the inducer hexamethyleneb- 
isacetamide (HMBA) was found to be correlated with 
the expression of specific PKC isoforms. In fast rate 
differentiating C44 cells the c-PKC isoforms, and partic- 
ularly a,-PKC, are highly represented [3], whereas in 
N23, slow rate differentiating cells, high levels of the 
GPKC isozyme are present [5]. (ii) In the early stages of 
HMBA-induced differentiation, 8-PKC (in N23 cells) [5] 
and a,-PKC (in C44 cells) [3] undergo down-regulation 
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PKC isoform detected with antia-PKC antibody, showing a lower M,. 
at the highest rate and to a larger extent. (iii) Introduc- 
tion of the qPKC in slow responding N23 cells or of the 
&PKC in fast differentiating C44 cells promotes in the 
first case a significant increase [6], and in the second case 
a large decrease [5] in the rate of appearance of benzid- 
ine-reactive cells. 
In order to extend this information and to better 
charaterize the role of PKC in MEL cell differentiation 
it was considered of interest to design experiments in- 
tended to establish the level and the type of PKC 
isoforms present in MEL cell clones showing low or high 
sensitivity to HMBA, as well as the rate and the extent 
of down- regulation of each PKC isoforms prior to cell 
commitment. 
2. Materials and methods 
2.1. Cell culture 
MEL cell clones N23 and V3.17.44, from now on named C44, were 
obtained and cultured as described [3]. Cell differentiation was induced 
by the addition of 5 mM HMBA to the culture at a cell density of 
lO’/ml. At the indicated times, the proportion of benzidine reactive cells 
was assayed by the benzidine reaction as described [7]. 
2.2. Immunoblot analysis of PKC isozymes in MEL cells 
MEL cells (4 x 10’ cells) were lysed and the soluble cell fraction 
prepared and submitted to DEAE chromatography as previously de- 
scribed [8]. Two peaks of PKC activity were detected, the first eluted 
at approximately 70 mM NaCl and containing both c- and n-PKC 
activities, the second eluted at approximately 120 mM NaCl containing 
only n-PKC activity. Samples (20 PUL of the eluted fractions were col- 
lected and submitted to 8% SDS-PAGE [9], followed by electroblotting 
onto Pure Nitrocellulose membrane (Bio-Rad). PKC isotypes were 
identified by using anti-PKC isotype-specific polyclonal rabbit antisera 
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as primary antibodies (Gibco BRL) for cc, /I, y, 6, E and c-PKC. The 
sequences of antigen peptides used to produce each antibody were as 
follow: peptide 313-326 for a-PKC, peptide 313-329 for B-PKC, pep- 
tide 306318 for y-PKC, peptide 662-673 for 6-PKC, peptide 726-737 
for .s-PKC, and peptide 577-592 for {-PKC [lo-121. The immunoreac- 
tive material was detected by the enhanced chemiluminescence method 
(ECL, Amersham International) [13] and the photographic films were 
scanned by a Shimadzu CS-9000 densitometer. The relative amount of 
each PKC isozyme was calculated from the area of the densitometric 
peaks. The linear range of the signal detected was previously deter- 
mined to obtain quantitative responses from each experiment. The two 
peaks were separately collected and the first one utilized for the succes- 
sive purification step by HA chromatography. 
2.3. Separation of c-PKC isozymes 
The first peak of PKC isozymes eluted from DEAE chromatography 
was concentrated by ultrafiltration, loaded onto a hydroxylhapatite 
column and chromatographed as previously described [3]. The assay of 
c-PKC activity was performed using samples of the eluted fractions 
(100 ~1) in the absence or in the presence of Ca*+, phosphatydilserine 
and diacylglycerol using histone SIII as substrate [8]. One unit of PKC 
activity is defined as the amount of enzyme which catalyzes the incorpo- 
ration of 1 pmol of phosphate into the substrate/min in the assay 
conditions. 
3. Results 
3.1. Types and levels of PKC isozymes in different MEL 
cell clones 
The PKC content of two MEL cell clones, N23 and 
C44, the former characterized by a low and the latter by 
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a high rate of differentiation, was analyzed by the use of 
antipeptide antibodies specifically raised against a, /3, y, 
6, E, and 5-PKC isoforms. To define the nature of PKC 
isozymes and to avoid undesired aspecific cross-reac- 
tions, the cell cytosolic fractions were first submitted to 
DEAE chromatography and the eluted fractions ana- 
lyzed for their content of PKC isozymes by immunoblot- 
ting with each antibody (Fig. 1). In both cell clones PKC 
isozymes separate into two peaks, the first one contain- 
ing a mixture of a, 6 and i-PKC; the second one contain- 
ing only E-PKC. However, the immunoblot obtained 
with the anti-a-PKC revealed the presence of two reac- 
tive proteins, (insert of Fig. l), one having a molecular 
mass corresponding to a-PKC (78 kDa), the other one 
showing a slightly smaller molecular mass of 74-76 kDa. 
Both proteins interact with the anti-a PKC antibody in 
a highly specific manner as demonstrated by antigen 
competition. Due to the fact that both proteins contain 
the same antigenic site, characteristic of the a-PKC 
isozyme, we have named the low M, isoform, identified 
in Western blot analysis, as a,-PKC. At present, no in- 
formation is available concerning the nature of the proc- 
ess causing the appearance of the a,-PKC. At present, no 
information is available concerning the nature of the 
process causing the appearance of the a,-PKC form in 
MEL cells. By comparison of the areas under each PKC 
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Fig. 1. Identification of PKC isozymes from MEL cell clones. N23 (A) and C44 (B) cells were lysed and submitted to DEAE-chromatography as 
described in section 2. The eluted fractions were assayed for reactivity with anti-PKC antipeptide antibodies (see section 2) following SDS-PAGE 
and immunoblotting. The immunocomplex was revealed with the ECL method, the amount of each PKC isozyme was calculated by the area of the 
peaks obtained from densitometric scanning of the photographic film and reported as arbitrary units. (L) a-PKC; (t ) a,-PKC; (0) CPKC; (m) E-PKC; 
(0) t-PKC. /3- and y-PKC isozymes were undetectable (data not shown). The insert shows the immunostaining obtained with fraction number 50 
and 70 (for E-PKC). a* represents the immunoblot obtained with anti-a-PKC antibody incubated in the presence of 10 pg of the peptide used to 
prepare the anti-a-PKC antibody. 
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Fig. 2. Separation and identification of c-PKC isozymes from MEL cells. The peaks containing the cPKC isozymes, eluted from the DEAE-cellulose 
chromatography (see Fig. 1) and obtained from N23 (A) or C44 cells (B), were submitted to HA-chromatography (see section 2), in conditions known 
to separate c-PKC isozymes. Aliquots (100 ~1) of the eluted fractions were assayed for PKC activity in the absence (0) or in the presence (0) of Ca2’, 
phosphatidylserine and diacylglycerol. Samples of 100 ~1 were also used for the evaluation of the cross-reactivity with anti-a-PKC antibody (w), as 
described in the legend to Fig. 1. The insert shows the immunostaining with anti-a-PKC antipeptide antibody of the indicated fractions submitted 
to SDS-PAGE. 
isozyme peak, it has been established that, with respect 
to N23 (Fig. lA), C44 cells (Fig. 1B) contain a higher 
amoung of cx-PKC and an approximately 5-times higher 
level of a,-PKC; in contrast E- and 6-PKC levels were 
found to be expressed at 1.6- and 4-fold lower level, 
respectively. The level of c-PKC was found to be almost 
identical in the two clones. No cross-reactive material, 
using anti-p-PKC and anti-y-PKC antibodies, was de- 
tected. 
In order to better characterize the two PKC forms 
recognized by the anti-a-PKC antibodies, the first peak 
eluted from the DEAE-cellulose chromatography and 
containing both cross-reacting proteins, was submitted to 
chromatography on HA column. The eluted fractions 
were then analyzed for their catalytic properties, as well as 
for their reactivity against anti-a-PKC antibody. As 
shown in Fig. 2, two peaks of PKC activity were sepa- 
rated from N23 (Fig. 2A) and C44 cells (Fig. 2B), fully 
active on histone S-III in the presence of Ca’+, phosphat- 
idylserine and diacylglycerol, confirming that both kina- 
ses belong to the c-PKC family. The immunoblotting of the 
eluted fractions revealed that the first minor peak con- 
tained almost exclusively the low M, protein, and that the 
second major peak contained the CZ-PKC iso- 
zyme. These results also confirmed a higher expression 
of a-PKC and expecially of a,-PKC isoform in C44 cells. 
3.2. Different down-regulation of PKC isozymes during 
MEL cell differentiation 
In N23 cells exposed to HMBA (Fig. 3A), S-PKC was 
rapidly degraded and, in approximately 46 h, 70% of 
the original protein was lost. Down-regulation of a,- 
PKC was almost completed in 14 h and accounted for 
the disappearance of approximately 60% of the protein, 
whereas the decay of ol-PKC proceeded at a slower rate 
and only after 24 h, 25% of the protein disappeared. In 
these conditions only a slight decay (10%) of .s-PKC 
isoforms was observed, whereas the level of {-PKC re- 
mained almost unchanged. A resistance of this atypical 
PKC isozyme [l] to down-regulation was also reported 
for activated glioma cells [14]. 
In C44 cells, the overall down-regulation process of 
PKC isoforms is more rapid (Fig. 3B) and involves espe- 
cially the a,-PKC isozyme, which is reduced up to 80% 
in 2-4 h, and the a-PKC which decreases by 60% in 6-8 
h. The level of S-PKC, by contrast, is only 25% reduced 
in the first 2 h, and also the level of E-PKC is slightly 
affected, while that of &PKC remains unmodified 
throughout incubation. These results provide clear indi- 
cation that down-regulation of each PKC isozyme is 
significantly different in these two cell lines and that the 
rate of the overall process is accelerated in the C44 cell 
clone. 
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Fig. 3. Changes in the levels of PKC isozymes during MEL cell differentiation. MEL cells N23 (A) or C44 (B) were induced with 5 mM HMBA 
and, at the indicated times, 5 x lo4 cells were collected and submitted to SDS-PAGE as reported in section 2. After electrophoresis, immunoblot 
analysis was performed as specified in section 2 using the various antipeptide antibodies. The amount of each PKC isoform was calculated from the 
area of the densitometric peaks. (A) a-PKC; (+) cz,-PKC; (0) GPKC; (m) c-PKC; (0) &PKC. 
4. Discussion 
The data presented in this paper extend the character- 
ization of the various PKC isoforms that are expressed 
in different amounts in MEL cell clones showing slow 
(N23) or fast (C44) rates of differentiation. 
In both cells clones, the presence of a, 6 and E-PKC 
was confirmed. An additional c-PKC, different in M, 
from a-PKC, but cross-reacting with anti-a-PKC anti- 
body, named a,, and t-PKC have also been demon- 
strated to be present. In C44 cells a-PKC and a,-PKC 
are highly represented, whereas in N23 the amounts of 
E- and particularly that of S-PKC are consistently higher. 
Thus an increased expression of c-PKC isoforms seems 
to be a characteristic property of the fast differentiating 
clone and, vice versa, a high level of expression of n-PKC 
isozymes representes a constitutive property of the slow 
responding clone. 
These conclusions are supported not only by previous 
findings indicating that introduction of the a,-PKC 
isoform in N23 [6], or of 6-PKC in C44 [5] cells induces, 
respectively, an increase or a decrease in the rate of 
differentiation; but also by the kinetics of down-regula- 
tion of each PKC isoform induced by HMBA in slow or 
fast responding MEL cells. In fact, the data reported in 
the present paper have demonstrated that the decay of 
the two PKC isoforms (a,-PKC and SPKC), largely 
expressed in the two MEL cell clones, occurs at a very 
rapid rate and is almost completed largely before cell 
commitment [3]. The rapid degradation of 6-PKC, 
that precedes also that of a,-PKC in N23 cells, may be 
interpreted as the removal of a negative signal on cell 
commitment, delivered by the former kinase. In C44 
cells, characterized by a constituvely low level of SPKC, 
the utilization of a,-PKC form is much more rapid and 
is correlated with the onset of cell commitment. Further 
experiments are in progress to characterize the biochem- 
ical mechanism responsible for modulation of the level 
of PKC isoforms in MEL cell differentiation. 
Recent results, obtained with PCR amplification ex- 
periments, carried out on cDNA from MEL cells have 
indicated that the f3-PKC [15,16] isozyme is also ex- 
pressed in this cell type (unpublished observations). The 
levels and the possible role of this kinase isozyme in 
MEL cells will be investigated in additional experiments. 
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